BECTON, DICKINSON AND COMPANY Funds and ETFs Becton, Dickinson and Company
Equities
BDX
US0758871091
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 235.4 USD | +0.77% |
|
-2.32% | -3.72% |
| May. 06 | Barclays Adjusts Price Target on Becton, Dickinson to $312 From $305, Keeps Overweight Rating | MT |
| May. 03 | TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $260 From $271 | MT |
ETFs positioned on Becton, Dickinson and Company
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.25% | 0 M€ | -.--% | ||
| 0.24% | 0 M€ | +2.74% | - | |
| 0.24% | 273 M€ | -.--% | ||
| 0.24% | 1,174 M€ | +23.54% | ||
| 0.24% | 655 M€ | -.--% | - | |
| 0.23% | 6 M€ | +17.98% | - | |
| 0.23% | 0 M€ | +6.45% | - | |
| 0.21% | 26 M€ | +16.85% | - | |
| 0.21% | 322 M€ | +13.88% | - | |
| 0.21% | 29 M€ | -.--% | - | |
| 0.20% | 1 M€ | -.--% | ||
| 0.20% | 206 M€ | -.--% | ||
| 0.20% | 284 M€ | -.--% | ||
| 0.19% | 0 M€ | +11.27% | - | |
| 0.19% | 23 M€ | -.--% | - | |
| 0.19% | 786 M€ | -.--% | ||
| 0.19% | 0 M€ | +18.93% | - | |
| 0.18% | 0 M€ | +11.81% | - | |
| 0.18% | 0 M€ | +7.52% | ||
| 0.17% | 0 M€ | +8.58% | - | |
| 0.16% | 205 M€ | -.--% | ||
| 0.16% | 14 M€ | +16.19% | - | |
| 0.15% | 0 M€ | +0.99% | - | |
| 0.15% | 0 M€ | +17.73% | ||
| 0.14% | 1,166 M€ | +0.26% | - |
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows:
- medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.;
- diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.;
- clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc.
Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Calendar
2024-05-14
- BofA Securities Health Care Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
233.6
USD
Average target price
278.8
USD
Spread / Average Target
+19.37%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.72% | 67.51B | |
| -4.79% | 183B | |
| -0.16% | 108B | |
| +3.81% | 50.67B | |
| +9.21% | 44.7B | |
| +2.41% | 40.95B | |
| +5.70% | 26.8B | |
| +2.73% | 26.71B | |
| +12.66% | 24.62B | |
| -13.28% | 21.38B |
- Stock Market
- Equities
- BDX Stock
- Funds and ETFs Becton, Dickinson and Company